MAP2K6 and non-small cell lung carcinoma: The results of RIP assay using anti-ILF3 antibody showed that the interaction of ILF3 with the 3'-UTR regions of MAP2K6 and E2F1 mRNA was reduced in NSCLC cells with PTTG3P depletion.